Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach

Abstract

DOI to the publisher's website.• The final author version and the galley proof are versions of the publication after peer review.• The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User Agreement:

A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers

“…Here we report the development, among different lipid matrices, of novel DDS for tetracaine. Factorial design was used as a chemometric tool to elucidate the effect of excipients in the NLC supramolecular organization, providing robust systems with optimized structural properties for subsequent analyses 13 . Among other biophysical techniques, Raman imaging and SANS analyses disclosed details on the lipid matrix organization, that reduced the shelf stability of one optimized formulation.…”

Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs

“…In principal, assembly of LNPs is achieved by rapid mixing of four lipids in ethanol with RNA molecules in an aqueous buffer (near pH 4) in a microfluidic or T-junction mixer [ [47] , [48] , [49] ].…”

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery

“…Introducing and evolving ethanol loading procedures facilitated effective production of homogenous, small-size (diameter < 100nm) LNPs with high entrapment efficiency (>80%) [34,[56][57][58]. Over the years, many ionizable lipids have been developed, with a variety of features depending on the desired purpose.…”